Massachusetts General Hospital, ADHD Program — Cambridge, Massachusetts

Massachusetts General Hospital, ADHD Program is a clinical research site located in Cambridge, Massachusetts, United States 02138.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital, ADHD Program has participated in 1 clinical trials.

Therapeutic areas: Attention Deficit Hyperactivity Disorder.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital, ADHD Program?

Massachusetts General Hospital, ADHD Program has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital, ADHD Program conducted?

Massachusetts General Hospital, ADHD Program has 1 clinical trials on record. Their work covers Attention Deficit Hyperactivity Disorder.

Is Massachusetts General Hospital, ADHD Program accredited by Crixeo Health?

Massachusetts General Hospital, ADHD Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital, ADHD Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.